According to Dermapharm's latest financial reports the company's current EPS (TTM) is $2.37. In 2022 the company made an earnings per share (EPS) of $2.60 a decrease over its 2021 EPS that were of $4.51.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.37 | -8.97% |
2022 | $2.60 | -42.21% |
2021 | $4.51 | 144.18% |
2020 | $1.85 | 14.58% |
2019 | $1.61 | -3.15% |
2018 | $1.66 | -34.2% |
2017 | $2.53 |